BRD2 and Dysmenorrhea: In this study, preoperative, 3rd-month, and 6th-month measurements of weight, BMI, FSH, LH, total testosterone, AMH, DHEA-S, SHBG, and androstenedione and dysmenorrhea were evaluated using the Kolmogorov–Smirnov test, which indicated that these variables were not normally distributed (p < 0.05).